1 | Cut-off level of serum caspase-cleaved CK 18 (M30) for diagnosis of acute on chronic liver failure in chronic hepatitis C cirrhosis | |
Page 1-7 | ||
Shymaa Aleraky; Sayed Abd Elmaqsood; Mohamed El-Saadany; Mohammed Al Arman; Hany Shabana | ||
2 | Mortality risk and associated factors in cirrhosis patients with SARS-CoV-2 infection | |
Page 9-16 | ||
Mostafa Elkady; Maha Omar; Mounir Saif Elnaser; Noha Roshdy | ||
3 | Hepatocellular carcinoma before and after the era of direct-acting antiviral therapy for chronic hepatitis C: Dose the story differ? | |
Page 17-22 | ||
Hany Shabana; Salah Elgamal; Ayman Menessy; Ehab Abdel-Khalek; Fatma Abozeid; Marwa Askar; Mohammed Mohsen; Abd- Elmohsen El-Desoky | ||